HomepageEarnings Events Newsdesk 19 hours ago AbbVie (ABBV) AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults AbbVie (NYSE: ABBV) FY 2026 Other Release Apple inc (AAPL) Horizon Quantum Announces Expected New Board Members and Chief Legal Officer » « Intercontinental Exchange, Inc (ICE) ICE Mortgage Monitor: Q4 Lending Climbs to 3.5-Year High as Refinance Activity Accelerates and Servicer Retention Strengthens Newsdesk: